Overview Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers Status: Not yet recruiting Trial end date: 2024-03-01 Target enrollment: Participant gender: Summary The goal of clinical trial is to evaluate the safety and tolerability of SCT650C in healthy participants. Phase: Phase 1 Details Lead Sponsor: Sinocelltech Ltd.